SCHEMBL23367000

SCHEMBL23367000

Cc1ncn(C)c1C(=O)CN

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
APOBEC3A P31941 4/20 0.41
APOBEC3G Q9HC16 3/20 0.41
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
TP53 P04637 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
FLT1 P17948 5/20 0.32
KDR P35968 4/20 0.32
ALDH1A1 P00352 2/20 0.31
MAPT P10636 1/20 0.31
KDM4E B2RXH2 1/20 0.31
HPGD P15428 2/20 0.31
DPP4 P27487 1/20 0.31
CTDSP1 Q9GZU7 2/20 0.31
BCAT2 O15382 1/20 0.30
LMNA P02545 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23354063 0.98 APOBEC3A (0.40) APOBEC3AAPOBEC3GNPC1RAB9ATP53
SCHEMBL25457959 0.83 APOBEC3A (0.46) APOBEC3AAPOBEC3GNPC1RAB9ASMN1; SMN2
SCHEMBL19797901 0.79 APOBEC3A (0.41) APOBEC3AAPOBEC3GNPC1RAB9ATP53
SCHEMBL20360594 0.78 KDM4E (0.49) APOBEC3AAPOBEC3GNPC1RAB9ATP53
SCHEMBL23354512 0.77 APOBEC3A (0.38) APOBEC3AAPOBEC3GNPC1RAB9ATP53
SCHEMBL23716719 0.75 APOBEC3A (0.41) APOBEC3AAPOBEC3GNPC1RAB9ATP53
SCHEMBL7375007 0.74 APOBEC3A (0.38) APOBEC3AAPOBEC3GNPC1RAB9ATP53
SCHEMBL23367111 0.74 APOBEC3A (0.41) APOBEC3AAPOBEC3GNPC1RAB9ASMN1; SMN2
SCHEMBL23716720 0.73 APOBEC3A (0.40) APOBEC3AAPOBEC3GNPC1RAB9ATP53
Hydrochloric Acid SCHEMBL23354199 0.73 APOBEC3A (0.40) APOBEC3AAPOBEC3GNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230027346-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2023-01-26 US disclosed
WO-2021094436-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2021-05-20 WO disclosed
EP-3822268-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS Bayer Aktiengesellschaft (DE) 2021-05-19 EP disclosed
US-20180194755-A1 Tetrahydropyranyl Benzamide Derivatives ELI LILLY AND COMPANY 2018-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180194755-A1 Tetrahydropyranyl Benzamide Derivatives INSR, GPR119, GLP1R APOBEC3A 3862/4885APOBEC3G 4168/4885NPC1 744/4885
US-20230027346-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS ADAMTS7, MMP7, ADAM17 APOBEC3A 545/4885APOBEC3G 602/4885NPC1 3479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.